UnitedHealthcare Expands Allergy IgE Testing Coverage

Reimbursable Specific IgE Tests Rise From 20 to 29 Allergens a Year for Patients 20 and Up

Rcmaxis Billing & Policy Update  ·  Posted October 23, 2026  ·  Effective: September 01, 2026 (CO, NC, NE, OH Exchange plans: October 01, 2026)

Summary of the Rule or Edit Change

UnitedHealthcare published the change in its October 2026 Commercial Reimbursement Policy (COMM RPUB) bulletin. The underlying benefit is in-vitro specific IgE allergy testing, the blood-draw panel ordered to identify which specific allergens (foods, pollens, dust, pet dander and so on) are triggering a patient's allergic symptoms, as an alternative or supplement to skin testing. The policy change itself is narrow: it raises the annual allowed count of individual allergen tests from 20 to 29 for members 20 years of age and older. The age band and most other coverage criteria in the policy are unchanged.

The effective date differs by market. UHC's main commercial policy update took effect September 1, 2026 nationally. A small group of Individual Exchange plans in Colorado, North Carolina, Nebraska and Ohio run on a separate bulletin cycle and pick up the same expanded allergen count October 1, 2026 instead. If your practice bills UHC Exchange plans in any of those four states, don't assume the September date applies; check the Exchange-specific bulletin.

For allergy, immunology and primary care practices that routinely order broad allergen panels, this is a practical win. A patient worked up for multi-allergen sensitization (common in complex asthma, atopic dermatitis or food-allergy evaluations) can now have nine more individual allergens tested and reimbursed in the same benefit year without running into the old cap and triggering a partial denial or forcing a second visit to spread testing across two benefit years.

Action Required for Billing Teams

The immediate task is small but has a real dollar consequence if you skip it: update your UHC allergy-testing benefit maximums in whatever system tracks authorization limits, so claims for allergen 21 through 29 in a benefit year don't get held or written off by staff who still remember the old 20-allergen ceiling.

Think about the volume this touches. A single-location allergy practice ordering a 25-30 allergen panel on complex patients might have been splitting those orders across two visits, or writing off the test lines past allergen 20, specifically for UHC commercial patients. If that practice sees even 15 UHC patients a month who need a full panel, and each of the newly covered 9 allergens pays in the range of $15-25 per individual IgE test under a typical commercial fee schedule, that's roughly $2,000-$3,400 a month in testing that used to be a write-off and now isn't, once your system reflects the new cap.

Our allergy and immunology billing guide covers the broader coding and documentation rules for IgE panels and skin testing side by side.